- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Ajanta Pharma conferred as "Best Managed Companies" in India by Deloitte
Mumbai: Ajanta Pharma, a specialty pharmaceutical formulation company, has been awarded as "Best Managed Companies" in India by Deloitte for 2022. The selection process for the award had rigorous evaluation of management abilities for Strategy; Capabilities and Innovation; Governance and Financials; Culture and Commitment.
Mr. Yogesh Agrawal, Managing Director, Ajanta Pharma received the award at the Best Managed Companies programme held on 14 October at Deloitte Knowledge Center in Mumbai.
Read also: NPPA panel fixes MRP of Ajanta Pharma Metoprolol Tartrate, lvabradine Hydrochloride FDC
"We are delighted to receive the Best Managed Companies award from Deloitte as it validates our emphasis on commitment towards excellence in people, processes, infrastructure and practices. This award is dedicated to over 7,000 motivated Ajantaites spread globally who make Ajanta an exciting and vibrant place to work." said Mr. Yogesh Agrawal.
Read also: Ajanta Pharma launches generic asthma drug in US market
Ajanta Pharma is a specialty pharmaceutical formulation company having branded generic business in India and 30 emerging markets, a generic business in the US, and an institution business in Africa. The company has 6 world-class formulations & 1 API manufacturing facility in India. Stringent authorities like the USFDA and WHO have approved the company's facilities at Paithan in Maharashtra and Dahej in Gujarat.
For the last 10 financial years, the company has posted healthy performance with its Revenue from Operations growing at 15% CAGR and net profit at 23% CAGR.
Read also: Ajanta Pharma board nod to Rs 286-crore share buyback plan
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751